Reply to Dr S.C. Palmer and co-workers

Nephrology Dialysis Transplantation

Volumn 23, Issue 8, 2008, Pages 2709-2710

  Olgaard, Klaus ^a   Lewin, Ewa ^b  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; ERYTHROPOIETIN; ESTROGEN; GESTAGEN; VITAMIN D;

CHRONIC KIDNEY DISEASE; HORMONE SUBSTITUTION; HUMAN; LETTER; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; VITAMIN D DEFICIENCY;

EVIDENCE-BASED MEDICINE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 48749126957     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn344     Document Type: Letter

References (3)

1. Olgaard K, Lewin E. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: a recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership. Nephrol Dial Transplant 2008; 23: 1786-1789
2. Palmer SC, McGregor DO, Macaskill P et al. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007; 147: 840-853
3. Tonelli M. Vitamin D in patients with chronic kidney disease: nothing new under the sun. Ann Intern Med 2007; 147: 880-881